Vaccinations and risk of central nervous system demyelinating diseases in adults
- PMID: 12707063
- DOI: 10.1001/archneur.60.4.504
Vaccinations and risk of central nervous system demyelinating diseases in adults
Abstract
Background: Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases.
Objective: To evaluate the association between vaccination and onset of multiple sclerosis or optic neuritis.
Design: Case-control study involving cases of multiple sclerosis or optic neuritis among adults 18 to 49 years of age. Data on vaccinations and other risk factors were obtained from computerized and paper medical records and from telephone interviews.
Setting: Three health maintenance organizations.
Participants: Four hundred forty case subjects and 950 control subjects matched on health maintenance organization, sex, and date of birth.
Interventions: None.
Main outcome measures: Onset of first symptoms of demyelinating disease at any time after vaccination and during specified intervals after vaccination (<1 year, 1-5 years, and >5 years).
Results: Cases and controls had similar vaccination histories. The odds ratios (95% confidence intervals), adjusted for potential confounding variables, of the associations between ever having been vaccinated and risk of demyelinating disease (multiple sclerosis and optic neuritis combined) were 0.9 (0.6-1.5) for hepatitis B vaccine; 0.6 (0.4-0.8) for tetanus vaccination; 0.8 (0.6-1.2) for influenza vaccine; 0.8 (0.5-1.5) for measles, mumps, rubella vaccine; 0.9 (0.5-1.4) for measles vaccine; and 0.7 (0.4-1.0) for rubella vaccine. The results were similar when multiple sclerosis and optic neuritis were analyzed separately. There was no increased risk according to timing of vaccination.
Conclusion: Vaccination against hepatitis B, influenza, tetanus, measles, or rubella is not associated with an increased risk of multiple sclerosis or optic neuritis.
Similar articles
-
Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.Brain. 2007 Apr;130(Pt 4):1105-10. doi: 10.1093/brain/awl368. Epub 2007 Feb 1. Brain. 2007. PMID: 17276994
-
Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.Arch Neurol. 2006 Jun;63(6):871-5. doi: 10.1001/archneur.63.6.871. Arch Neurol. 2006. PMID: 16769869
-
Vaccination history and risk of childhood leukaemia.Int J Epidemiol. 2005 Oct;34(5):1100-9. doi: 10.1093/ije/dyi113. Epub 2005 Jun 10. Int J Epidemiol. 2005. PMID: 15951359
-
[Vaccination needed by over 50-year-old persons].MMW Fortschr Med. 2003 Nov 6;145(45):26-8. MMW Fortschr Med. 2003. PMID: 14699802 Review. German.
-
Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?J Autoimmun. 2000 Feb;14(1):1-10. doi: 10.1006/jaut.1999.0346. J Autoimmun. 2000. PMID: 10648110 Review.
Cited by
-
A review of neuro-ophthalmic sequelae following COVID-19 infection and vaccination.Front Cell Infect Microbiol. 2024 Jan 17;14:1345683. doi: 10.3389/fcimb.2024.1345683. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38299114 Free PMC article. Review.
-
Optic Neuritis following Second Administration of COVID-19 Vaccine: A Case Report.Case Rep Ophthalmol. 2023 Aug 23;14(1):394-399. doi: 10.1159/000531526. eCollection 2023 Jan-Dec. Case Rep Ophthalmol. 2023. PMID: 37901633 Free PMC article.
-
Exploring the optimal vaccination strategy against hepatitis B virus in childhood (Review).Biomed Rep. 2023 Jun 9;19(1):48. doi: 10.3892/br.2023.1631. eCollection 2023 Jul. Biomed Rep. 2023. PMID: 37383679 Free PMC article. Review.
-
Association between vaccination and the risk of central demyelination: results from a case-referent study.J Neurol. 2023 Oct;270(10):4678-4686. doi: 10.1007/s00415-023-11822-y. Epub 2023 Jun 23. J Neurol. 2023. PMID: 37351662 Free PMC article.
-
Immunopathogenesis of viral infections in neurological autoimmune disease.BMC Neurol. 2023 May 23;23(1):201. doi: 10.1186/s12883-023-03239-x. BMC Neurol. 2023. PMID: 37221459 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical